DESCRIPTION: Mirataz is the first, only transdermal medication approved by the FDA to manage feline weight loss. This ointment contains the active ingredient Mirtazapine, and it comes in the form of a topical, easy-to-apply ointment that is administered in the inner earlobe of the cat. It then absorbs into the animal's bloodstream through his or her skin.
Key Benefits:
Mirtazapine is known to antagonize many receptors (H1 histamine receptors, 5-HT3, 5-HT2C, and 5-HT2A serotonin receptors, and presynaptic a2 receptors). This causes enhanced release of noradrenaline (NE)2 and serotonin (5-HT), and interaction with nuclei within the hypothalamus 1.
Formulated For: For use in cats
How is Medication Given?
To topically administer, apply a 1.5-inch ribbon (around 0.1 mL, or 2 mg per cat) onto the inner pinna inside the ear. Repeat daily for a 14-day period. Following application, ensure that animals and people in the home don't make contact with the cat for 2 hours. Mirtazapine is orally and transdermally absorbed. Follow your veterinarian's directions when using this product.
What Results Can I Expect? Mirataz:
Is a topically-applied, easy-to-use ointment Is intended for application in the inner feline earlobe Is an FDA-approved prescription medication Controls unwanted weight loss in cats who have underlying conditions, such as gastrointestinal, dental, or kidney disease
What Form Does Medication Come In?Ointment
Dose and Administration: Sold in a tube containing 5 grams.
Possible Side Effects: Clinical study findings showed that the most common side effects included:
Vomiting Abnormal behavior (such as hyperactivity or vocalization) Reactions at the application site
Precautions:
Never instill in the eye or administer orally. Not proven safe for use in lactating, pregnant, or breeding cats, kittens under the age of 6 months, or cats weighing under 2 kg. Monitor your cat's food intake after withdrawing treatment. Administer cautiously to cats with kidney or hepatic disease. Wear gloves to handle or apply, and wash your hands after handling. Do not allow contact between any person or animal and the treated cat for 2 hours post-application. Mirtazapine can be orally and transdermally absorbed. Not for use in humans. Never use in a cat treated with an MAOI. Never administer to a cat with a known hypersensitivity to Mirtazapine or an excipient. Only for topical use in felines, and only to be used with supervision of a veterinarian. Keep out of reach of animals and children.
Storage Recommendations: Store at room temperature between 20 to 25 degrees C (68 to 77 degrees F). Discard within 30 days of first use.
In Case of Overdose: Call your nearest emergency pet hospital.
